0001104659-22-084772.txt : 20220801 0001104659-22-084772.hdr.sgml : 20220801 20220801170617 ACCESSION NUMBER: 0001104659-22-084772 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220728 FILED AS OF DATE: 20220801 DATE AS OF CHANGE: 20220801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHADE CHRISTIAN S CENTRAL INDEX KEY: 0001214496 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 221125647 MAIL ADDRESS: STREET 1: MEDAREX STREET 2: 707 STATE ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aprea Therapeutics, Inc. CENTRAL INDEX KEY: 0001781983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6095104718 MAIL ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 4 1 tm2222147-9_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-07-28 0 0001781983 Aprea Therapeutics, Inc. APRE 0001214496 SCHADE CHRISTIAN S 535 BOYLSTON STREET BOSTON MA 02116 1 0 0 0 Common Stock 2022-07-28 4 A 0 32400 0 A 259246 D Common Stock 1000 I By adult child Common Stock 1000 I By adult child Common Stock 1000 I By adult child Common Stock 1000 I By adult child Common Stock 1000 I By adult child Common Stock 1000 I By adult child Common Stock 5000 I By spouse Stock Option (right to Buy) 1.09 2022-07-28 4 A 0 47600 0 A 2032-07-28 Common Stock 47600 47600 D These shares represent restricted stock units which were granted on July 28, 2022, and which will vest and be settled in common stock on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions. The option vests in full on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, or for any other purpose. /s/ Scott M. Coiante, attorney-in-fact 2022-08-01